- Home
- CVAC vs USNA Comparison
CVAC vs USNA Comparison
Compare CVAC & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- USNA
- Stock Information
- Founded
- CVAC 2000
- USNA 1992
- Country
- CVAC Germany
- USNA United States
- Employees
- CVAC N/A
- USNA N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- USNA Medicinal Chemicals and Botanical Products
- Sector
- CVAC Health Care
- USNA Health Care
- Exchange
- CVAC Nasdaq
- USNA Nasdaq
- Market Cap
- CVAC 643.8M
- USNA 765.5M
- IPO Year
- CVAC 2020
- USNA 1996
- Fundamental
- Price
- CVAC $2.82
- USNA $36.26
- Analyst Decision
- CVAC Hold
- USNA Hold
- Analyst Count
- CVAC 3
- USNA 1
- Target Price
- CVAC $10.00
- USNA $38.00
- AVG Volume (30 Days)
- CVAC 399.6K
- USNA 96.0K
- Earning Date
- CVAC 11-12-2024
- USNA 10-22-2024
- Dividend Yield
- CVAC N/A
- USNA N/A
- EPS Growth
- CVAC N/A
- USNA N/A
- EPS
- CVAC N/A
- USNA 2.86
- Revenue
- CVAC $70,565,734.00
- USNA $875,117,000.00
- Revenue This Year
- CVAC $105.61
- USNA N/A
- Revenue Next Year
- CVAC N/A
- USNA $1.91
- P/E Ratio
- CVAC N/A
- USNA $12.83
- Revenue Growth
- CVAC 75.11
- USNA N/A
- 52 Week Low
- CVAC $2.22
- USNA $34.76
- 52 Week High
- CVAC $6.30
- USNA $57.78
- Technical
- Relative Strength Index (RSI)
- CVAC 38.84
- USNA 44.17
- Support Level
- CVAC $2.79
- USNA $35.58
- Resistance Level
- CVAC $2.89
- USNA $37.07
- Average True Range (ATR)
- CVAC 0.11
- USNA 0.94
- MACD
- CVAC -0.01
- USNA 0.12
- Stochastic Oscillator
- CVAC 19.44
- USNA 43.35
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.